| Molecular sample |
Two FNA passes |
One FNA pass |
| Diagnostic cytology interpretation |
Central facility or local institution (if agreement made) |
Central facility or local institution |
| Mutations analyzed |
346 genes (761 variants) |
112 genes (12,135 variants) |
| Gene fusions analyzed |
130 gene fusions |
>120 gene fusions |
| Chromosomal copy number alterations |
Loss of heterozygosity analysis |
10 chromosomal regions |
| Molecular results |
Malignancy classifier positive |
Negative (3% cancer probability) |
| GSC benign (4% cancer probability) |
Currently negative (5–10% cancer probability) |
| GSC suspicious (~50% cancer probability) |
Positive—mutation details and cancer probability stated for each |
